SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board: 
Last Post: 5/26/2017 7:49:54 PM - Followers: 1331 - Board type: Free - Posts Today: 0

Biotech Values is a forum for discussing 
all facets of biotech investing with an emphasis
on fundamental analysis and avoiding scams.
We generally do not discuss microcap stocks.

Calendars and Compilations
Webcasts
Recent Biotech Buyouts
Buyouts of Biotech Partners
FoB Collaborations

Common Biotech-Newbie Mistakes
Biotech Holdings of Selected Institutional Investors
US Patent Expirations for Big-Selling Biologics
Biotech and Miscellaneous Acronyms

Top Twitter Feeds for Biotech Info
iHub's Greatest Hits (thru 5/09)

PostSubject
#211547  Sticky Note TGTX establishes $300M(!) ATM facility: DewDiligence 05/26/17 05:17:25 PM
#211528  Sticky Note Interesting analysis from a biostatistician. iwfal 05/26/17 09:15:39 AM
#211522  Sticky Note looks like an existing shareholder is interested in dewophile 05/25/17 09:52:21 PM
#211515  Sticky Note ODAC endorses PFE’s Epogen FoB for all indications DewDiligence 05/25/17 04:51:28 PM
#211499  Sticky Note RVNC—The proprietary peptide in RT002’s formulation reduces (but DewDiligence 05/25/17 10:58:40 AM
#210691  Sticky Note MNTA—Interchangeable Humira FoB for US market is badly needed: DewDiligence 04/18/17 03:36:02 PM
#211548   I was thinking about these issues some, and iwfal 05/26/17 07:49:53 PM
#211547   TGTX establishes $300M(!) ATM facility: DewDiligence 05/26/17 05:17:25 PM
#211545   Anavex Thank you Peter. I get that they DFRAI 05/26/17 04:11:14 PM
#211544   i jsut read the paper and not convinced masterlongevity 05/26/17 03:12:57 PM
#211543   Haven’t seriously followed MNKD in several years; I DewDiligence 05/26/17 02:57:05 PM
#211541   Hello Dew....been following for a long time....do you purdue pete 05/26/17 02:21:45 PM
#211540   Yes - I agree you could readily get biomaven0 05/26/17 01:06:25 PM
#211539   …computationally impractical to find the [pairing] that minimizes DewDiligence 05/26/17 12:05:45 PM
#211538   >>If the pairing is random, how can it biomaven0 05/26/17 11:57:25 AM
#211537   OCRX can’t be accused of not trying—they’re hosting DewDiligence 05/26/17 11:54:56 AM
#211536   ZYME IPO has rare partial exercise of underwriter’s option: DewDiligence 05/26/17 11:51:47 AM
#211535   KITE—PDUFA date for CAR-T/NHL BLA is 11/29/17 (with DewDiligence 05/26/17 11:40:45 AM
#211534   Now randomly pair members of the control DewDiligence 05/26/17 11:17:22 AM
#211533   Thanks - appreciate the informed commentary. biomaven0 05/26/17 11:11:28 AM
#211532   TRIL sells 6.41M* common &convertible-preferred shares @US$5.00—an 8% DewDiligence 05/26/17 10:55:55 AM
#211531   Those splits have nothing to do with the dewophile 05/26/17 10:21:50 AM
#211530   >>The PML patient had been on Tysabri until zipjet 05/26/17 09:23:33 AM
#211529   My only comment is that if another "authority" swampboots 05/26/17 09:23:11 AM
#211528   Interesting analysis from a biostatistician. iwfal 05/26/17 09:15:39 AM
#211527   TRIL- I have followed TRIL for a number biotech_researcher 05/26/17 09:09:23 AM
#211526   Yes management bungled this. My guess is they dewophile 05/26/17 09:04:19 AM
#211525   TRIL - a single investor slated to take DFRAI 05/26/17 08:45:04 AM
#211524   AERI sells 1.40M shares @$53.75—a 1% discount to DewDiligence 05/26/17 07:07:08 AM
#211523   good catch... biocqr 05/25/17 11:19:39 PM
#211522   looks like an existing shareholder is interested in dewophile 05/25/17 09:52:21 PM
#211521   Masterlongevity I stumbled on this re your comments DFRAI 05/25/17 05:37:23 PM
#211520   CORI sells 6.44M* shares @$6.25—a 9% discount to DewDiligence 05/25/17 05:31:47 PM
#211519   SNDX sells 4.31M* shares @$13.25—a 5% discount DewDiligence 05/25/17 05:31:02 PM
#211518   AKAO sells 5.75M* shares @$22.50—a 5% discount to DewDiligence 05/25/17 05:30:31 PM
#211517   Please also see 211516 post DFRAI 05/25/17 05:20:55 PM
#211516   Anavex citations - comments much appreciated DFRAI 05/25/17 05:13:33 PM
#211515   ODAC endorses PFE’s Epogen FoB for all indications DewDiligence 05/25/17 04:51:28 PM
#211514   tau and amyloid both important. most likely masterlongevity 05/25/17 04:42:30 PM
#211513   I never met the CEO, so no comment DFRAI 05/25/17 04:38:47 PM
#211512   This is not totally unexpected, but it does dewophile 05/25/17 04:36:01 PM
#211511   TRIL > Trillium Therapeutics launches equity offering; shares biocqr 05/25/17 04:10:51 PM
#211510   Ot: I need your autograph , if swampboots 05/25/17 03:52:47 PM
#211509   Anavex has the solution to this puzzle. DFRAI 05/25/17 03:44:43 PM
#211508   Re: MSI-High ciotera 05/25/17 03:08:49 PM
#211507   Humm, tau not amyloids, or just Merck hedging swampboots 05/25/17 02:19:19 PM
#211506   i appreciate your weighing in and adding color. dewophile 05/25/17 01:46:20 PM
#211505   Interesting analysis from a biostatistician. His main complaint biomaven0 05/25/17 01:44:26 PM
#211504   MSI-High within that already small population is not genisi 05/25/17 12:35:54 PM
#211503   JMP Securities initiates coverage of CLSD with "outperform." bladerunner1717 05/25/17 11:29:21 AM
#211502   Oppenheimer initiates coverage of MEIP with "outperform." Stock bladerunner1717 05/25/17 11:26:48 AM
#211501   MRK licenses anti-tau drug from Japan’s Teijin Pharma: DewDiligence 05/25/17 11:14:12 AM
#211500   AERI +33% on data from second phase-3 for DewDiligence 05/25/17 11:08:59 AM
#211499   RVNC—The proprietary peptide in RT002’s formulation reduces (but DewDiligence 05/25/17 10:58:40 AM
#211498   BCRX +34% on positive interim p2 data in Titan V 05/25/17 10:26:06 AM
#211497   Dew, are you aware of any stated bio-chemical marthambles 05/25/17 10:21:14 AM
PostSubject